8WE4 image
Entry Detail
PDB ID:
8WE4
EMDB ID:
Title:
SARS-CoV-2 Omicron XBB.1.5 RBD complexed with human ACE2 and S304
Biological Source:
PDB Version:
Deposition Date:
2023-09-17
Release Date:
2024-07-24
Method Details:
Experimental Method:
Resolution:
2.91 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Angiotensin-converting enzyme 2
Chain IDs:A
Chain Length:805
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Spike protein S1
Chain IDs:B
Chain Length:223
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Description:S304 Fab Heavy Chain
Chain IDs:C (auth: H)
Chain Length:231
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:S304 Fab Light Chain
Chain IDs:D (auth: L)
Chain Length:216
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins.
Embo J. 43 1484 1498 (2024)
PMID: 38467833 DOI: 10.1038/s44318-024-00062-z

Abstact

Since SARS-CoV-2 Omicron variant emerged, it is constantly evolving into multiple sub-variants, including BF.7, BQ.1, BQ.1.1, XBB, XBB.1.5 and the recently emerged BA.2.86 and JN.1. Receptor binding and immune evasion are recognized as two major drivers for evolution of the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the underlying mechanism of interplay between two factors remains incompletely understood. Herein, we determined the structures of human ACE2 complexed with BF.7, BQ.1, BQ.1.1, XBB and XBB.1.5 RBDs. Based on the ACE2/RBD structures of these sub-variants and a comparison with the known complex structures, we found that R346T substitution in the RBD enhanced ACE2 binding upon an interaction with the residue R493, but not Q493, via a mechanism involving long-range conformation changes. Furthermore, we found that R493Q and F486V exert a balanced impact, through which immune evasion capability was somewhat compromised to achieve an optimal receptor binding. We propose a "two-steps-forward and one-step-backward" model to describe such a compromise between receptor binding affinity and immune evasion during RBD evolution of Omicron sub-variants.

Legend

Protein

Chemical

Disease

Primary Citation of related structures